What is the first‑line treatment for uncomplicated syphilis, including dosing, pregnancy considerations, alternative regimens, partner management, and follow‑up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Uncomplicated Syphilis

Benzathine penicillin G 2.4 million units intramuscularly as a single dose is the definitive first-line treatment for primary, secondary, and early latent syphilis, achieving 90-100% treatment success. 1, 2

Treatment Regimens by Stage

Primary and Secondary Syphilis

  • Benzathine penicillin G 2.4 million units IM as a single injection is the standard treatment for adults with primary or secondary syphilis 1, 3
  • This single-dose regimen is supported by more than four decades of clinical experience with excellent efficacy 1
  • All patients diagnosed with syphilis should be tested for HIV at the time of diagnosis 1

Early Latent Syphilis (≤1 year duration)

  • Benzathine penicillin G 2.4 million units IM as a single dose is recommended 1
  • Early latent syphilis is defined as infection acquired within the preceding year, documented by seroconversion, fourfold increase in titer, history of symptoms within the past year, or having a sex partner with documented early syphilis 1

Late Latent Syphilis or Syphilis of Unknown Duration (>1 year)

  • Benzathine penicillin G 7.2 million units total, administered as three weekly injections of 2.4 million units IM is the standard regimen 1, 3
  • CSF examination should be performed before treatment in patients with neurologic or ophthalmic signs/symptoms, evidence of active tertiary syphilis, treatment failure, HIV infection with late latent syphilis, or nontreponemal titer ≥1:32 1
  • If a dose is missed during weekly therapy, an interval of 10-14 days between doses might be acceptable, but pregnant patients who miss any dose must repeat the entire course 1

Alternative Regimens for Penicillin-Allergic Patients

Non-Pregnant Adults with Early Syphilis (Primary, Secondary, or Early Latent)

  • Doxycycline 100 mg orally twice daily for 14 days is the preferred alternative 1, 4
  • Tetracycline 500 mg orally four times daily for 14 days is an acceptable alternative, but doxycycline is preferred due to better compliance with twice-daily versus four-times-daily dosing 1, 4
  • Close clinical and serological follow-up is essential for all patients treated with alternative regimens 4

Non-Pregnant Adults with Late Latent Syphilis

  • Doxycycline 100 mg orally twice daily for 28 days is the recommended alternative 1, 4
  • Tetracycline 500 mg orally four times daily for 28 days is also acceptable 1
  • A CSF examination must exclude neurosyphilis before using any non-penicillin regimen for late latent infection 1

Ceftriaxone as a Second-Line Alternative

  • Ceftriaxone 1 gram IM or IV daily for 10-14 days may be considered when doxycycline cannot be used 1, 5
  • Critical caveat: Patients with severe penicillin allergy (such as Stevens-Johnson syndrome) may also be allergic to ceftriaxone, as both are beta-lactam antibiotics 1
  • The optimal dose and duration have not been definitively established, and evidence for late latent and tertiary syphilis is extremely limited 1

Avoid Azithromycin

  • Azithromycin should NOT be used in the United States due to widespread macrolide resistance and documented treatment failures 1, 6

Pregnancy Considerations

Mandatory Penicillin Treatment

  • All pregnant women with penicillin allergy MUST undergo desensitization followed by penicillin treatment—no exceptions 1, 4, 5
  • Penicillin is the only therapy with documented efficacy for preventing maternal transmission to the fetus and treating fetal infection 7, 1
  • Tetracycline, doxycycline, erythromycin, azithromycin, and ceftriaxone are inadequate—erythromycin does not reliably cure fetal infection 1

Screening Requirements

  • All pregnant women should be screened for syphilis at the first prenatal visit, during the third trimester (at 28 weeks), and at delivery 1, 3
  • Any woman who delivers a stillborn infant after 20 weeks' gestation should be tested for syphilis 7

Jarisch-Herxheimer Reaction Risk

  • Women treated during the second half of pregnancy are at risk for premature labor and/or fetal distress from Jarisch-Herxheimer reaction 1
  • Women should seek immediate medical attention if they notice contractions or changes in fetal movements after treatment 1

Enhanced Treatment Considerations

  • Some experts recommend a second dose of benzathine penicillin 2.4 million units IM administered 1 week after the initial dose for women with primary, secondary, or early latent syphilis 7, 1

Partner Management

Presumptive Treatment Criteria

  • Persons exposed within 90 days preceding the diagnosis of primary, secondary, or early latent syphilis should be treated presumptively even if seronegative 1
  • Persons exposed >90 days before diagnosis should be treated presumptively if serologic test results are not immediately available and follow-up is uncertain 1

Time Windows for At-Risk Partners

  • Primary syphilis: 3 months plus duration of symptoms 1
  • Secondary syphilis: 6 months plus duration of symptoms 1
  • Early latent syphilis: 1 year 1
  • Long-term partners of patients with late syphilis should undergo clinical and serologic evaluation 1

Follow-Up Protocol

Primary and Secondary Syphilis

  • Perform quantitative nontreponemal serologic tests (RPR or VDRL) at 6 and 12 months after treatment 1
  • A fourfold decline in titer is expected within 6 months for primary/secondary syphilis 1

Late Latent Syphilis

  • Repeat quantitative nontreponemal tests at 6,12, and 24 months 1, 4
  • A fourfold decline in titer is expected within 12-24 months for late syphilis 1

Treatment Failure Indicators

  • Re-treat and evaluate for HIV if any of the following occur: 1
    • Persistent or recurring signs/symptoms
    • Sustained fourfold increase in nontreponemal titers
    • Failure of initially high titer (≥1:32) to decline at least fourfold within 6-12 months for early syphilis or 12-24 months for late syphilis
  • Unless reinfection is likely, lumbar puncture should be performed to evaluate for neurosyphilis in cases of treatment failure 1
  • Re-treatment typically involves three weekly injections of benzathine penicillin G 2.4 million units IM, unless CSF examination indicates neurosyphilis 1

Serofast State

  • Remember that 15-25% of successfully treated patients remain "serofast" with persistent low titers (<1:8) that do not indicate treatment failure 1

HIV-Infected Patients

Treatment Regimens

  • HIV-infected patients have the same treatment regimens as non-HIV-infected patients 1
  • Penicillin regimens should be used for all stages of syphilis in HIV-infected patients 1
  • Patients with penicillin allergy should undergo skin testing and desensitization, then be treated with penicillin 1

Enhanced Monitoring

  • HIV-infected patients may have atypical serologic responses but generally respond well to standard treatment 1
  • Closer follow-up is mandatory to detect potential treatment failure or disease progression 1
  • For patients treated with alternative regimens, monitoring should occur at 3-month intervals instead of 6-month intervals 4, 5
  • HIV-infected patients who have either late latent syphilis or syphilis of unknown duration should have a CSF examination before treatment 7

Follow-Up for HIV-Infected Patients with Late Latent Syphilis

  • Patients should be evaluated clinically and serologically at 6,12,18, and 24 months after therapy 7
  • If at any time clinical symptoms develop or nontreponemal titers rise fourfold, a repeat CSF examination should be performed and treatment administered accordingly 7

Neurosyphilis Treatment

First-Line Therapy

  • Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 1

Alternative Penicillin-Based Regimen (Outpatient)

  • Procaine penicillin 2.4 million units IM once daily plus probenecid 500 mg orally four times daily for 10-14 days is acceptable when adherence can be assured 1
  • Critical caveat: Procaine penicillin without probenecid is inadequate because it fails to achieve therapeutic CSF penicillin levels 1
  • Patients with known sulfonamide allergy should not receive the procaine-penicillin + probenecid regimen, as they are highly likely to be allergic to probenecid 1

Supplemental Therapy

  • Some clinicians add three weekly intramuscular doses of benzathine penicillin G 2.4 million units after the IV course to provide additional coverage, although consensus on this practice has not been reached 1

Ceftriaxone for Neurosyphilis

  • If ceftriaxone must be used for neurosyphilis, the dose is 2 grams daily IV (not IM) for 10-14 days, with very limited supporting data 1

Common Pitfalls to Avoid

  • Do not use oral penicillin preparations for syphilis treatment as they are ineffective 1
  • Do not rely solely on treponemal test antibody titers to assess treatment response, as they correlate poorly with disease activity 1
  • Do not use different testing methods (e.g., switching between VDRL and RPR) when monitoring serologic response, as results cannot be directly compared 1
  • Do not substitute inadequate alternatives in pregnancy—only penicillin prevents congenital syphilis 1
  • Do not use azithromycin in the United States due to widespread resistance 1

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Treatment of Syphilis in Non-Pregnant Individuals Allergic to Penicillin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternative Antibiotics for Syphilis in Patients Allergic to Both Penicillin and Doxycycline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: Re-emergence of an old foe.

Microbial cell (Graz, Austria), 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.